Differential effects of suramin on protein kinase C isoenzymes. A novel tool for discriminating protein kinase C activities (Q41064697)

26 September 2017

Differential effects of suramin on protein kinase C isoenzymes. A novel tool for discriminating protein kinase C activities (English)

1 reference

26 September 2017

1 reference

Gschwendt M

1

1 reference

26 September 2017

Kittstein W

series ordinal

2

1 reference

26 September 2017

Johannes FJ

series ordinal

3

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

26 September 2017

1 reference

26 September 2017

421

1 reference

26 September 2017

2

1 reference

26 September 2017

165-168

1 reference

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Suramin in the treatment of AIDS: mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Location and characterization of the suramin binding sites of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Cathepsin G is a strong platelet agonist released by neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Suramin inhibits DNA damage in human prostate cancer cells treated with topoisomerase inhibitors in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Characterization of activators and inhibitors of protein kinase C mu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

PH domain: the first anniversary

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Immunological demonstration of protein kinase C mu in murine tissues and various cell lines. Differential recognition of phosphorylated forms and lack of down-regulation upon 12-O-tetradecanoylphorphol-13-acetate treatment of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Expression and characterization of PKD, a phorbol ester and diacylglycerol-stimulated serine protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Partial purification of a type eta protein kinase C from murine brain: separation from other protein kinase C isoenzymes and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

A phorbol ester and phospholipid-activated, calcium-unresponsive protein kinase in mouse epidermis: characterization and separation from protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Lack of an effect of novel inhibitors with high specificity for protein kinase C on the action of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate on mouse skin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Inhibition of Neutrophil Serine Proteinases by Suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Suramin, an experimental chemotherapeutic drug, irreversibly blocks T cell CD45-protein tyrosine phosphatase in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

In vitro activation and substrates of recombinant, baculovirus expressed human protein kinase C mu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

Regulation of protein kinase Cmu by basic peptides and heparin. Putative role of an acidic domain in the activation of the kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2901530-5

10.1016/S0014-5793(97)01530-5

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference